Author

Francesca Battaglin

University of Southern CaliforniaORCID 0000-0002-9869-0163Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Evanthia T. Roussos TorresiD· 1 shared Heinz‐Josef LenziD· 1 shared Jingyi Jessica LiiD· 1 shared Lili ZhouiD· 1 shared Priscilla ChaniD· 1 shared Priya JayachandraniD· 1 shared Remo RohsiD· 1 shared Shannon M. MumenthaleriD· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Evanthia T. Roussos TorresORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Targeting circadian transcriptional programs in triple negative breast cancer through a cis-regulatory mechanism

Yuanzhong Pan, Tsu-Pei Chiu, Lili Zhou, Priscilla Chan, Tia Tyrsett Kuo, Francesca Battaglin, Shivani Soni, Priya Jayachandran, Jingyi Jessica Li, Heinz‐Josef Lenz, Shannon M. Mumenthaler, Remo Rohs, Evanthia T. Roussos Torres, Steve A. Kay

This paper identifies a cis-regulatory mechanism in triple-negative breast cancer where targeting circadian transcription factors with small molecules represses a circadian transcriptional program, offering a new therapeutic strategy.

bioRxiv · Apr 26, 2024 · PreprintCancer Biology